ARCHIVES

Challoner: We Recommended FDA Replace 510(k) Clearance

This article is from The Cancer Letter archive.

Vol. 40 No. 27 | July 4, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Approves Bayer’s Xofigo For Late-Stage Prostate Cancer

May 31, 2013

Tykerb Plus Letrozole Delayed Metastatic Breast Cancer

January 30, 2009

Maryland’s Greenebaum Cancer Center Wins NCI Designation.

September 12, 2008

Six NY Institutes Form Cancer Vaccine Collaboration

November 8, 2002

Racial Disparities Remain In Breast Cancer Care

October 29, 2010

DCT Board Approves Drug Development Recompetition

November 30, 1990